Citi Reaffirms Their Hold Rating on DR Horton (DHI)
In a report released today, Anthony Pettinari from Citi maintained a Hold rating on DR Horton, with a price target of $162.00.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Pettinari covers the Consumer Cyclical sector, focusing on stocks such as DR Horton, Graphic Packaging, and International Paper Co. According to TipRanks, Pettinari has an average return of 16.2% and a 68.03% success rate on recommended stocks.
In addition to Citi, DR Horton also received a Hold from KBW’s Jade Rahmani in a report issued yesterday. However, on January 22, Argus Research maintained a Buy rating on DR Horton (NYSE: DHI).
Based on DR Horton’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $6.89 billion and a net profit of $594.8 million. In comparison, last year the company earned a revenue of $7.61 billion and had a net profit of $844.9 million
Read More on DHI:
Disclaimer & DisclosureReport an Issue
- D.R. Horton price target lowered to $163 from $168 at Keefe Bruyette
- U.S. Housing Inflection Point Puts D.R. Horton (DHI) in Pole Position
- D.R. Horton price target raised to $185 from $175 at Argus
- D.R. Horton price target raised to $169 from $167 at Evercore ISI
- D.R. Horton price target lowered to $158 from $162 at BofA
